US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Mei Pharma, Inc. (MM) (MSHL)
Mei Pharma, Inc. (MM) (MSHL) ニュース

MSHL

Marshall Edwards (MSHL)

Mei Pharma, Inc. (MM)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2012/07/10	03 : 41	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/07/06	05 : 03	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/07/03	04 : 18	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/28	22 : 00	PR Newswire (US)	Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/06	19 : 04	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/06	06 : 28	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/06/04	22 : 00	PR Newswire (US)	Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/29	22 : 00	PR Newswire (US)	Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/26	02 : 32	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (SC 13D/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	04 : 27	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02 : 14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02 : 13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/16	02 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/15	23 : 05	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/14	22 : 00	PR Newswire (US)	Marshall Edwards Completes Rights Offering To Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/05/08	22 : 00	PR Newswire (US)	Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/25	22 : 00	PR Newswire (US)	Marshall Edwards Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/14	04 : 59	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/12	03 : 41	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/10	22 : 00	PR Newswire (US)	Marshall Edwards Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidat...	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/04/03	22 : 00	PR Newswire (US)	Marshall Edwards Announces Data from Clinical Trial of ME-143 Selected for Presentation at ASCO Annual Meeting	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/31	01 : 34	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/31	01 : 32	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/28	22 : 00	PR Newswire (US)	Marshall Edwards CEO to Present at Needham Healthcare Conference	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	22 : 00	PR Newswire (US)	Marshall Edwards Receives Notice of Effectiveness for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	19 : 02	Edgar (US Regulatory)	Notice of Effectiveness (EFFECT)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/27	05 : 40	Edgar (US Regulatory)	Prospectus filed pursuant to Rule 424(b)(3) (424B3)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/20	21 : 55	Edgar (US Regulatory)	Securities Registration Statement (S-1/A)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/19	22 : 00	PR Newswire (US)	Marshall Edwards Announces Terms for Rights Offering to Stockholders	NASDAQ:MSHL	Mei Pharma, Inc. (MM)
2012/03/08	02 : 17	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:MSHL	Mei Pharma, Inc. (MM)

Showing the most relevant articles for your search:NASDAQ:MSHL

1 2 3 4 5 6 7 8 9 10 次へ >>

US Dollar vs Euro

Gold vs US Dollar

Deutsche Telekom (QX)

Bank of America

Invesco QQQ Trust Series 1

Verizon Communications

US Dollar vs Sterling

BNP Paribas (QX)

Energy Select Sector SPDR

Financial Select Sector

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約